AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Discover the importance of using asset allocation to balance risk and return. This strategy can enhance your investment performance.
28,655 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Legend Awakes closes a weeks-long mystery teaser with a cinematic reveal, introducing Alberich Token and a narrative-...
AI-driven capital spending is set to surge, pushing capex crosses trillion next. Here are two industrial stocks—Verti...
The home-improvement aisle is crowded with options, but two names stand out: Lowe's and Floor & Decor. This article b...
MoonPay seals its fourth acquisition of the year, bringing Decent into the fold as it launches MoonPay Trade to strea...
Goldfinch outlines a phased wind-down of its Prime unit, shifting from growth to borrower recoveries and testing whet...
BWET, the Breakwave Tanker Shipping ETF, has surged more than 1,000% year-to-date, defying AI-focused bets. The move...
American Express reveals plans for a 55-floor headquarters at the World Trade Center site, targeting 2031 completion ...
May 2026 brings a reshaped broker landscape as traders weigh the best interactive brokers alternatives. cost, tools, ...
A high-stakes take on the AI shift: palantir’s billionaire says only two paths will endure—master a skilled trade or ...
Trust Wallet has unveiled automatic Address Poisoning Protection to shield users from spoofing attacks. The feature a...
Futures markets push the S&P 500 above 7,500 as renewed Iran Strait optimism reduces oil pressure. Analysts warn the ...